SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

ProKidney Reports Third Quarter 2026 Financial Results and Business Highlights

On track to deliver pivotal Phase 3 PROACT 1 surrogate endpoint (eGFR slope) topline results in Q2 2

PROK

Related stories